Delaware
|
11-2481903
|
(State
or other jurisdiction of incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
1450
Broadway, New York, NY
|
10018
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Page
No.
|
|||
Part
I.
|
Financial
Information
|
|||
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
|
Condensed
Consolidated Balance Sheets - September 30, 2007 (unaudited) and
December
31, 2006
|
|
3
|
|
|
Unaudited
Condensed Consolidated Income Statements - Three and Nine Months
Ended
September 30, 2007 and 2006
|
|
4
|
|
|
Unaudited
Condensed Consolidated Statement of Stockholders' Equity - Nine Months
Ended September 30, 2007
|
|
5
|
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows - Nine Months Ended
September 30, 2007 and 2006
|
|
6
|
|
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
|
8
|
|
|
|
|
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
|
17
|
|
|
|
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
|
21
|
|
|
|
|
|
|
Item
4.
|
Controls
and Procedures
|
|
21
|
|
|
|
|
|
|
Part
II.
|
Other
Information
|
|
22
|
|
|
|
|
|
|
Item
1.
|
Legal
Proceedings
|
|
22
|
|
Item
1A.
|
Risk
Factors
|
|
22
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
24
|
||
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
24
|
||
Item
5
|
Other
Information
|
|
24
|
|
Item
6.
|
Exhibits
|
|
24
|
|
|
|
|
|
|
Signatures
|
|
|
25
|
|
September
30,
|
December
31,
|
|||||
|
2007
|
2006
|
|||||
Assets
|
(unaudited)
|
|
|||||
Current
Assets:
|
|
|
|||||
Cash
and cash equivalents (including restricted cash of $3,647 in 2007
and
$4,268 in 2006)
|
$
|
255,987
|
$
|
77,840
|
|||
Cash
and cash equivalents in escrow for pending acquisition
|
24,000
|
-
|
|||||
Marketable
securities
|
13,000
|
-
|
|||||
Accounts
receivable, net of reserve for doubtful accounts of $3,050 in 2007
and
$1,633 in 2006
|
31,304
|
14,548
|
|||||
Due
from affiliate
|
200
|
297
|
|||||
Promissory
note receivable
|
1,000
|
1,000
|
|||||
Deferred
income tax assets
|
3,028
|
3,440
|
|||||
Prepaid
advertising and other
|
5,644
|
2,704
|
|||||
Total
Current Assets
|
334,163
|
99,829
|
|||||
Property
and equipment:
|
|||||||
Furniture,
fixtures and equipment
|
2,837
|
2,769
|
|||||
Less:
Accumulated depreciation and amortization
|
(1,502
|
)
|
(1,385
|
)
|
|||
|
1,335
|
1,384
|
|||||
Other
Assets:
|
|||||||
Restricted
cash
|
14,507
|
11,659
|
|||||
Goodwill
|
101,026
|
93,593
|
|||||
Trademarks
and other intangibles, net
|
745,463
|
467,688
|
|||||
Deferred
financing costs, net
|
7,519
|
3,355
|
|||||
Non-current
deferred income tax assets
|
28,143
|
17,970
|
|||||
Other
|
4,751
|
5,574
|
|||||
|
901,409
|
599,839
|
|||||
Total
Assets
|
$
|
1,236,907
|
$
|
701,052
|
|||
|
|||||||
Liabilities
and Stockholders' Equity
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
9,409
|
$
|
7,043
|
|||
Accounts
payable, subject to litigation
|
4,886
|
4,886
|
|||||
Deferred
revenue
|
3,686
|
1,644
|
|||||
Current
portion of long-term debt
|
25,882
|
22,132
|
|||||
Total
current liabilities
|
43,863
|
35,705
|
|||||
|
|||||||
Deferred
income taxes
|
69,066
|
59,054
|
|||||
Long-term
debt, less current maturities
|
616,297
|
140,676
|
|||||
Long
term deferred revenue
|
520
|
160
|
|||||
Total
Liabilities
|
729,746
|
235,595
|
|||||
|
|||||||
Commitments
and contingencies
|
|||||||
|
|||||||
Stockholders'
Equity
|
|||||||
Common
stock, $.001 par value
-
shares authorized 150,000; shares issued 56,956 and 56,227
respectively
|
57
|
57
|
|||||
Additional
paid-in capital
|
466,249
|
468,881
|
|||||
Retained
earnings (deficit)
|
41,715
|
(2,814
|
)
|
||||
Accumulated
other comprehensive loss
|
(193
|
)
|
-
|
||||
Less:
Treasury stock - 198 shares at cost
|
(667
|
)
|
(667
|
)
|
|||
Total
stockholders' equity
|
507,161
|
465,457
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
1,236,907
|
$
|
701,052
|
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
|
|
|
|
|
|||||||||
Licensing
and commission revenue
|
$
|
42,681
|
$
|
22,113
|
$
|
112,593
|
$
|
53,791
|
|||||
|
|||||||||||||
Selling,
general and administrative expenses
|
13,400
|
6,072
|
30,130
|
17,572
|
|||||||||
Special
charges
|
(39
|
)
|
632
|
1,055
|
1,900
|
||||||||
|
|||||||||||||
Operating
income
|
29,320
|
15,409
|
81,408
|
34,319
|
|||||||||
|
|||||||||||||
Other
expenses:
|
|||||||||||||
Interest
expense
|
9,299
|
3,441
|
20,706
|
8,620
|
|||||||||
Interest
and other income
|
(4,580
|
)
|
(277
|
)
|
(6,452
|
)
|
(629
|
)
|
|||||
Interest
- net and other income
|
4,719
|
3,164
|
14,254
|
7,991
|
|||||||||
|
|||||||||||||
Income
before income taxes
|
24,601
|
12,245
|
67,154
|
26,328
|
|||||||||
|
|||||||||||||
Provision
for income taxes
|
7,608
|
4,299
|
22,625
|
2,680
|
|
||||||||
|
|||||||||||||
Net
income
|
$
|
16,993
|
$
|
7,946
|
$
|
44,529
|
$
|
23,648
|
|||||
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
|
$
|
0.30
|
$
|
0.20
|
$
|
0.79
|
$
|
0.62
|
|||||
|
|||||||||||||
Diluted
|
$
|
0.28
|
$
|
0.18
|
$
|
0.73
|
$
|
0.54
|
|||||
|
|||||||||||||
|
|||||||||||||
Weighted
average number of common shares outstanding:
|
|||||||||||||
Basic
|
56,801
|
39,782
|
56,569
|
38,075
|
|||||||||
|
|||||||||||||
Diluted
|
61,380
|
44,818
|
61,289
|
43,469
|
Accumulated
|
||||||||||||||||||||||
Additional
|
Retained
|
Other
|
||||||||||||||||||||
|
Common
Stock
|
Paid
- in
|
Earnings/
|
Comprehensive
|
Treasury
|
|
||||||||||||||||
|
Shares
|
Amount
|
Capital
|
(Deficit)
|
Loss
|
Stock
|
Total
|
|||||||||||||||
Balance
at January 1, 2007
|
56,227
|
$
|
57
|
$
|
468,881
|
$
|
(2,814
|
)
|
$
|
-
|
$
|
(667
|
)
|
$
|
465,457
|
|||||||
Warrants
issued to non-employee related to the acquisition of
Danksin®
|
-
|
-
|
2,260
|
-
|
-
|
-
|
2,260
|
|||||||||||||||
Warrants
issued to non-employee related to the acquisition of
Rocawear®
|
-
|
-
|
2,671
|
-
|
-
|
-
|
2,671
|
|||||||||||||||
Common
stock issued to non-employee related to the acquisition of
Danksin®
|
13
|
-
|
241
|
-
|
-
|
-
|
241
|
|||||||||||||||
Common
stock issued to non-employee related to the acquisition of
Rocawear®
|
12
|
-
|
255
|
-
|
-
|
-
|
255
|
|||||||||||||||
Exercise
of stock options and warrants
|
684
|
-
|
1,962
|
-
|
-
|
-
|
1,962
|
|||||||||||||||
Stock
option compensation
|
-
|
-
|
135
|
-
|
-
|
-
|
135
|
|||||||||||||||
Tax
benefit of stock option exercise
|
-
|
-
|
928
|
-
|
-
|
-
|
928
|
|||||||||||||||
Amortization
in connection with restricted stock
|
20
|
-
|
1,207
|
-
|
-
|
-
|
1,207
|
|||||||||||||||
Expenses
related to common stock issuance
|
-
|
-
|
(184
|
)
|
-
|
-
|
-
|
(184
|
)
|
|||||||||||||
Net
cost of hedge on convertible note
|
-
|
-
|
(12,107
|
)
|
-
|
-
|
-
|
(12,107
|
)
|
|||||||||||||
Comprehensive
income:
|
||||||||||||||||||||||
Net
income
|
-
|
-
|
-
|
44,529
|
-
|
-
|
44,529
|
|||||||||||||||
Change
in fair value of cash flow hedge
|
(193
|
)
|
(193
|
)
|
||||||||||||||||||
Total
comprehensive income
|
-
|
-
|
-
|
-
|
-
|
-
|
44,336
|
|||||||||||||||
Balance
at September 30, 2007
|
56,956
|
$
|
57
|
$
|
466,249
|
$
|
41,715
|
$
|
(193
|
)
|
$
|
(667
|
)
|
$
|
507,161
|
|
Nine
Months Ended September 30,
|
||||||
|
2007
|
2006
|
|||||
|
|
|
|||||
Cash
flows from operating activities:
|
|
|
|||||
Net
income
|
$
|
44,529
|
$
|
23,648
|
|||
Depreciation
of property and equipment
|
117
|
157
|
|||||
Amortization
of intangibles
|
3,869
|
1,365
|
|||||
Amortization
of deferred financing costs
|
847
|
600
|
|||||
Provision
for doubtful accounts
|
1,606
|
904
|
|||||
Stock
option compensation
|
1,342
|
140
|
|||||
Accrued
interest on long-term debt
|
419
|
-
|
|||||
Other
comprehensive loss
|
(193
|
)
|
-
|
||||
Deferred
income tax provision
|
22,442
|
2,680
|
|||||
Changes
in operating assets and liabilities, net of business
acquisitions:
|
|||||||
Accounts
receivable
|
(18,362
|
)
|
(9,180
|
)
|
|||
Due
from affiliate
|
97
|
(51
|
)
|
||||
Prepaid
advertising and other
|
(2,940
|
)
|
(422
|
)
|
|||
Other
assets
|
823
|
232
|
|||||
Deferred
revenue
|
2,402
|
(1,630
|
)
|
||||
Accounts
payable and accrued expenses
|
1,057
|
327
|
|||||
Net
cash provided by operating activities
|
58,055
|
18,770
|
|||||
Cash
flows from investing activities:
|
|||||||
Purchases
of property and equipment
|
(68
|
)
|
(558
|
)
|
|||
Acquisition
of Mudd®
|
-
|
(45,787
|
)
|
||||
Acquisition
of London Fog®
|
-
|
(30,735
|
)
|
||||
Acquisition
of Danskin
|
(71,035
|
)
|
-
|
||||
Acquisition
of Rocawear
|
(205,534
|
)
|
-
|
||||
Purchase
of trademarks
|
(110
|
)
|
(1,269
|
)
|
|||
Cash
and cash equivalents placed in escrow
|
(24,000
|
)
|
-
|
||||
Purchase
of marketable securities
|
(196,400
|
)
|
(78
|
)
|
|||
Sale
of marketable securities
|
183,400
|
-
|
|||||
Net
cash used in investing activities
|
(313,747
|
)
|
(78,427
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Proceeds
from long-term debt
|
493,531
|
78,000
|
|||||
Proceeds
from the sale of warrants
|
37,491
|
-
|
|||||
Payment
for purchase of convertible note hedge
|
(76,303
|
)
|
-
|
||||
Proceeds
from exercise of stock options and warrants
|
1,742
|
4,231
|
|||||
Payment
of long-term debt
|
(14,579
|
)
|
(6,863
|
)
|
|||
Payment
of expenses related to common stock issuance
|
(184
|
)
|
-
|
||||
Deferred
financing costs
|
(5,011
|
)
|
(550
|
)
|
|||
Restricted
cash - current
|
621
|
(11,961
|
)
|
||||
Restricted
cash - non-current
|
(2,848
|
)
|
(5,593
|
)
|
|||
Net
cash provided by financing activities
|
434,460
|
57,264
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
178,768
|
(2,393
|
)
|
||||
Cash
and cash equivalents, beginning of period
|
73,572
|
7,593
|
|||||
Cash
and cash equivalents, end of period
|
$
|
252,340
|
$
|
5,200
|
|||
|
|||||||
Balance
of restricted cash - current
|
3,647
|
16,055
|
|||||
Total
cash and cash equivalents including current restricted cash, end
of
period
|
$
|
255,987
|
$
|
21,255
|
|
Nine
Months Ended
September
30,
|
||||||
|
2007
|
2006
|
|||||
|
|
|
|||||
Cash
paid during the period:
|
|
|
|||||
Interest
|
$
|
17,950
|
$
|
7,150
|
|||
|
|||||||
Income
Taxes
|
$
|
1,576
|
$
|
-
|
|
Nine
Months Ended
September
30,
|
||||||
|
2007
|
2006
|
|||||
|
|
|
|||||
Acquisitions:
|
|
|
|||||
Common
stock issued
|
$
|
496
|
$
|
54,969
|
|||
Warrants
issued - acquisition cost
|
$
|
4,931
|
$
|
4,596
|
|||
|
|||||||
Issuance
of promissory note
|
$
|
-
|
$
|
750
|
|||
|
|||||||
Net
cost of hedge on convertible note
|
$
|
12,107
|
$
|
-
|
(000's
omitted except share information)
|
|
|
|||||
Cash
paid at closing to sellers
|
$
|
70,000
|
|||||
Fair
value of 12,500 shares of $.001 par value common stock, at $19.33
fair
market value per share issued as a cost of the
acquisition
|
$
|
241
|
|||||
Fair
value of 30,000 warrants ($20.18 exercise price) issued as a cost
of the
acquisition
|
284
|
||||||
Fair
value of 133,334 warrants ($8.81 exercise price) issued as a cost
of the
acquisition
|
1,976
|
||||||
Total
equity consideration
|
2,501
|
||||||
Other
estimated costs of the acquisition
|
1,782
|
||||||
Total
|
$
|
74,283
|
Trademarks
|
$
|
71,700
|
||
License
agreements
|
1,700
|
|||
Goodwill
|
883
|
|||
Total
allocated preliminary purchase price
|
$
|
74,283
|
(000's
omitted except share information)
|
|
|
|||||
Cash
paid at closing to sellers
|
$
|
204,000
|
|||||
Fair
value of 12,500 shares of $.001 par value common stock, at $20.40
fair
market value per share issued as a cost of acquisition
|
255
|
||||||
Fair
value of 55,000 warrants ($20.40 exercise price) issued as a cost
of the
acquisition
|
562
|
||||||
Fair
value of 133,334 warrants ($8.81 exercise price) issued as a cost
of the
acquisition
|
2,109
|
||||||
Total
equity consideration
|
2,926
|
||||||
Other
estimated costs of the acquisition
|
3,208
|
||||||
Total
|
$
|
210,134
|
|
Total
|
2007
|
2008
|
2009
|
2010
|
2011
|
thereafter
|
|||||||||||||||
Due
to Sweet (Note J)
|
$
|
3,230
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
3,230
|
$
|
-
|
||||||||
Kmart
Note
|
3,781
|
3,781
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||
Asset
backed notes
|
142,339
|
19,976
|
21,760
|
23,704
|
25,822
|
36,773
|
14,304
|
|||||||||||||||
Term
Loan Facility
|
211,438
|
2,125
|
2,125
|
2,125
|
2,125
|
2,125
|
200,813
|
|||||||||||||||
Convertible
Notes
|
281,391
|
-
|
-
|
-
|
-
|
-
|
281,391
|
|||||||||||||||
Total
Debt
|
$
|
642,179
|
$
|
25,882
|
$
|
23,885
|
$
|
25,829
|
$
|
27,947
|
$
|
42,128
|
$
|
496,508
|
|
Nine
months ended
|
|||
|
September
30,
|
|||
|
2007
|
|||
Expected
Volatility
|
.30-.50
|
|||
Expected
Dividend Yield
|
0
|
%
|
||
Expected
Life (Term)
|
3-5
|
years | ||
Risk-Free
Interest Rate
|
3.00-4.75
|
%
|
|
Weighted-Average
|
||||||
|
Options
|
Exercise
Price
|
|||||
Outstanding
January 1, 2007
|
5,769,632
|
$
|
4.35
|
||||
Granted
|
-
|
-
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
(290,339
|
)
|
5.56
|
||||
Expired
|
-
|
-
|
|||||
Outstanding
September 30, 2007
|
5,479,293
|
$
|
4.28
|
||||
Exercisable
at September 30, 2007
|
5,382,625
|
$
|
4.21
|
|
Weighted-Average
|
||||||
|
Warrants
|
Exercise
Price
|
|||||
Outstanding
January 1, 2007
|
799,175
|
$
|
11.02
|
||||
Granted
in connection with Sold Warrants (see Note E)
|
3,628,450
|
42.40
|
|||||
Granted
|
80,000
|
20.32
|
|||||
Canceled
|
-
|
-
|
|||||
Exercised
|
(702,275
|
)
|
11.34
|
||||
Expired
|
-
|
-
|
|||||
Outstanding
September 30, 2007
|
3,805,350
|
$
|
41.08
|
||||
Exercisable
at September 30, 2007
|
176,900
|
$
|
13.96
|
For
the Quarter Ended
|
|
For
the Nine Months Ended
|
|
||||||||||
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
|
||||
(in
millions)
|
|
2007
|
|
2006
|
|
2007
|
|
2006
|
|||||
Basic
|
|||||||||||||
Net
income
|
$
|
16,993
|
$
|
7,946
|
$
|
44,529
|
$
|
23,648
|
|||||
Weighted
average common shares outstanding
|
56,801
|
39,782
|
56,569
|
38,075
|
|||||||||
Basic
earnings per share
|
$
|
0.30
|
$
|
0.20
|
$
|
0.79
|
$
|
0.62
|
|||||
Diluted
|
|||||||||||||
Net
income
|
$
|
16,993
|
$
|
7,946
|
$
|
44,529
|
$
|
23,648
|
|||||
Weighted
average common shares outstanding
|
56,801
|
39,782
|
56,569
|
38,075
|
|||||||||
Effect
of dilutive securities:
|
|||||||||||||
Employee
stock options and restricted stock
|
4,579
|
5,036
|
4,720
|
5,394
|
|||||||||
Weighted
average common shares and share
equivalents
outstanding
|
61,380
|
44,818
|
61,289
|
43,469
|
|||||||||
Diluted
earnings per share
|
$
|
0.28
|
$
|
0.18
|
$
|
0.73
|
$
|
0.54
|
· |
could
impair our liquidity;
|
· |
could
make it more difficult for us to satisfy our other
obligations;
|
· |
Require
us to dedicate a substantial portion of our cash flow
to payments on our
debt obligations, which reduces the availability of our
cash flow to fund
working capital, capital expenditures and other corporate
requirements;
|
· |
could
impede us from obtaining additional financing in
the future for working
capital, capital expenditures, acquisitions and general corporate
purposes;
|
· |
impose
restrictions on us with respect to future
acquisitions;
|
· |
make
us more vulnerable in the event of a downturn
in our business prospects
and could limit our flexibility to plan for,
or react to, changes in our
licensing markets; and
|
· |
place
us at a competitive disadvantage when
compared to our competitors who have
less debt.
|
Month
of purchase
|
Total
number
of
shares
purchased(1)
|
Average
price
paid
per share
|
Total
number of shares purchased as part of publicly announced plan or
program
|
Maximum
dollar
value
of shares
that
may yet be
purchased
under
the
program
|
|||||||||
July
1 - July 31 2007
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
August
1 - August 31, 2007
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
September
1 -September 30, 2007
|
2,428
|
$
|
22.90
|
$
|
—
|
$
|
—
|
||||||
Total
|
2,428
|
$
|
22.90
|
$
|
—
|
$
|
—
|
(1)
|
|
Represents
shares of common stock surrendered to the Company to pay employee
withholding taxes due upon the vesting of restricted
stock.
|
Director
|
Votes
Cast “For”
|
Votes
Withheld
|
|||||
Neil
Cole
|
51,418,337
|
1,149,655
|
|||||
Barry
Emanuel
|
51,266,877
|
1,301,115
|
|||||
Steven
Mendelow
|
52,009,142
|
558,850
|
|||||
Drew
Cohen
|
50,097,668
|
2,470,324
|
|||||
F.
Peter Cuneo
|
52,008,953
|
559,039
|
|||||
Mark
Friedman
|
51,878,957
|
689,035
|
Votes
Cast “For”
|
Votes
Cast “Against”
|
Votes
“Abstaining”
|
|||||
46,928,957
|
5,585,057
|
53,978
|
Votes
Cast “Against”
|
Votes
“Abstaining”
|
||||||
51,901,702
|
624,711
|
41,579
|
Exhibit
No.
|
|
Description
of Exhibit
|
|
|
|
Exhibit
2.1 (1)*
|
Purchase
and Sale Agreement, dated September 16, 2007, by and among Iconix
Brand
Group, Inc., Official Pillowtex, LLC and the Sellers of interests
in
Official Pillowtex, LLC (the “Sellers)
|
|
Exhibit
3(i)
|
|
Certificate
of Incorporation, as amended.
|
|
|
|
Exhibit
10.1(1)
|
|
Escrow
Agreement dated September 6, 2007 by and between Iconix Brand Group,
Inc.,
Ben Kraner, on behalf of the Sellers as each Seller’s authorized
attorney-in-fact, and the escrow agent.
|
|
|
|
Exhibit
31.1
|
|
Certification
of Chief Executive Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302
Of The
Sarbanes-Oxley Act of 2002.
|
|
|
|
Exhibit
31.2
|
|
Certification
of Chief Financial Officer Pursuant To Rule 13a-14 or 15d-14 of The
Securities Exchange Act of 1934, As Adopted Pursuant To Section 302
Of The
Sarbanes-Oxley Act of 2002.
|
|
|
|
Exhibit
32.1
|
|
Certification
of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As
Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002.
|
|
|
|
Exhibit
32.2
|
|
Certification
of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As
Adopted
Pursuant To Section 906 of The Sarbanes-Oxley Act of
2002.
|
* |
Iconix
Brand Group, Inc. has omitted certain schedules and exhibits pursuant
to
Item 601(b)(2) of Regulation S-K and shall furnish supplementally
to the
SEC copies of any of the omitted schedules and exhibits upon request
by
the SEC.
|
Iconix
Brand Group, Inc.
(Registrant)
|
|||
Date:
November 6, 2007
|
/s/
Neil Cole
|
||
Neil Cole
Chairman of the Board, President
and
Chief Executive Officer
(on
Behalf of the
Registrant)
|
Date:
November 6, 2007
|
/s/ Warren Clamen | ||
Warren Clamen
Chief
Financial Officer
|
/s/
Neil Cole
|
|||
Neil Cole |
|||
President
and Chief Executive Officer
|
/s/
Warren Clamen
|
|||
Warren
Clamen
|
|||
Chief
Financial Officer
|
/s/
Neil Cole
|
|||
Neil
Cole
|
|||
President
and Chief Executive Officer
|
/s/
Warren Clamen
|
|||
Warren
Clamen
|
|||
Chief
Financial Officer
|